| Breakdown | TTM | Feb 2026 | Feb 2025 | Feb 2024 | Feb 2023 | Feb 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 52.53B | 61.39B | 50.28B | 49.80B | 44.12B | 41.80B |
| Gross Profit | 19.26B | 22.33B | 18.57B | 18.62B | 17.02B | 15.41B |
| EBITDA | 3.94B | 5.71B | 4.07B | 4.62B | 4.55B | 3.74B |
| Net Income | 2.99B | 4.08B | 2.25B | 2.66B | 2.90B | 2.22B |
Balance Sheet | ||||||
| Total Assets | 47.86B | 46.81B | 27.08B | 25.42B | 22.75B | 19.96B |
| Cash, Cash Equivalents and Short-Term Investments | 26.91B | 17.70B | 12.81B | 11.47B | 9.26B | 9.20B |
| Total Debt | 18.06B | 11.55B | 4.18B | 2.57B | 2.06B | 1.65B |
| Total Liabilities | 30.43B | 27.41B | 11.07B | 9.67B | 8.51B | 7.72B |
| Stockholders Equity | 17.20B | 19.12B | 15.88B | 15.55B | 14.05B | 12.06B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.63B | 2.14B | 2.75B | 1.82B | 2.02B |
| Operating Cash Flow | 0.00 | 2.09B | 2.96B | 3.25B | 2.26B | 2.52B |
| Investing Cash Flow | 0.00 | 27.92M | -1.83B | -3.51B | -950.73M | -1.19B |
| Financing Cash Flow | 0.00 | 1.66B | -308.52M | -599.78M | -605.02M | -705.73M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥12.91B | 14.72 | ― | 2.91% | 7.68% | 39.87% | |
75 Outperform | ¥4.36B | 31.21 | ― | 3.70% | 7.31% | 109.18% | |
71 Outperform | ¥4.97B | 3.41 | ― | ― | 0.36% | ― | |
68 Neutral | ¥31.79B | 8.57 | ― | 2.71% | 4.27% | 27.62% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
63 Neutral | ¥62.29B | 34.13 | ― | 2.96% | 10.63% | 7.42% | |
54 Neutral | ¥5.77B | 19.88 | ― | ― | -1.71% | -303.36% |